Section 906 Sarbanes-Oxley Act Certification by Officers of Oxygen Therapy, Inc. for Q1 2017
This document is a certification by the President and Chief Financial Officer of Oxygen Therapy, Inc. stating that the company's Quarterly Report for the period ending March 31, 2017, complies with SEC requirements and fairly presents the company's financial condition. The certification is made pursuant to Section 906 of the Sarbanes-Oxley Act, confirming the accuracy and completeness of the report to the best of their knowledge.
Exhibit 2.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Oxygen Therapy, Inc. (the “Company”) for the quarter ending March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Yuval Kwintner, President and Ola Soderquist, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:
(1) The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: May 15, 2017 | By: | /s/ Yuval Kwintner |
| Yuval Kwintner | ||
| President | ||
| /s/ Ola Soderquist | ||
| Ola Soderquist | ||
| Chief Financial Officer |
